ROYAL BANK OF CANADA - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 27 filers reported holding NRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$44,000
-47.0%
170,419
-0.5%
0.00%
Q2 2023$83,000171,233
+135799.2%
0.00%
Q1 2023$0126
-1.6%
0.00%
Q4 2022$0128
-59.7%
0.00%
Q3 2022$0318
-39.2%
0.00%
Q2 2022$0
-100.0%
523
-93.5%
0.00%
Q2 2021$93,0008,0000.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 61,583$294,0000.03%
Alpine Global Management, LLC 25,326$121,0000.02%
Owl Creek Asset Management, L.P. 50,000$239,0000.02%
Engineers Gate Manager LP 25,210$121,0000.01%
Belvedere Trading LLC 26,900$89,0000.00%
Wealthcare Advisory Partners LLC 13,000$62,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 37,105$177,0000.00%
Belvedere Trading LLC 11,000$36,0000.00%
Psagot Value Holdings Ltd. / (Israel) 2,000$10,0000.00%
Quantbot Technologies LP 1,700$8,0000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders